Healthcare provider profile · identity verified

Peter Arthur Radice, M.D.

Internal Medicine · NEW PORT RICHEY, FL · NPI 1356339170

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Oxycodone Hcl	Oxycodone Hcl	398	86
Alprazolam	Alprazolam	336	72
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	317	93
Gabapentin	Gabapentin	300	85
Lorazepam	Lorazepam	210	61
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	204	46
Tramadol Hcl	Tramadol Hcl	198	66
Pregabalin	Pregabalin	186	38
Quetiapine Fumarate	Quetiapine Fumarate	165	39
Atorvastatin Calcium	Atorvastatin Calcium	163	58
Clonazepam	Clonazepam	159	35
Levothyroxine Sodium	Levothyroxine Sodium	139	48
Morphine Sulfate Er	Morphine Sulfate	134	30
Trazodone Hcl	Trazodone Hcl	131	39
Amlodipine Besylate	Amlodipine Besylate	130	43
Eliquis	Apixaban	130	29
Furosemide	Furosemide	127	49
Lisinopril	Lisinopril	123	45
Oxycontin	Oxycodone Hcl	120	18
Zolpidem Tartrate	Zolpidem Tartrate	120	30
Hydromorphone Hcl	Hydromorphone Hcl	116	25
Diazepam	Diazepam	114	21
Metoprolol Tartrate	Metoprolol Tartrate	100	32
Pantoprazole Sodium	Pantoprazole Sodium	95	32
Metoprolol Succinate	Metoprolol Succinate	89	35
Temazepam	Temazepam	86	18
Omeprazole	Omeprazole	81	22
Fentanyl	Fentanyl	78	13
Metformin Hcl	Metformin Hcl	78	21
Baclofen	Baclofen	76	22
Rosuvastatin Calcium	Rosuvastatin Calcium	75	24
Sertraline Hcl	Sertraline Hcl	73	19
Potassium Chloride	Potassium Chloride	70	26
Losartan Potassium	Losartan Potassium	67	29
Escitalopram Oxalate	Escitalopram Oxalate	66	12
Celecoxib	Celecoxib	62	15
Famotidine	Famotidine	62	19
Oxybutynin Chloride	Oxybutynin Chloride	61	12
Tamsulosin Hcl	Tamsulosin Hcl	60	25
Clopidogrel	Clopidogrel Bisulfate	59	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	12
Donepezil Hcl	Donepezil Hcl	57	20
Hydrochlorothiazide	Hydrochlorothiazide	54	12
Duloxetine Hcl	Duloxetine Hcl	53	14
Simvastatin	Simvastatin	47	15
Bumetanide	Bumetanide	44	14
Mirtazapine	Mirtazapine	44	11
Divalproex Sodium	Divalproex Sodium	43	12
Memantine Hcl	Memantine Hcl	43	17
Methadone Hcl	Methadone Hcl	42	11
Meloxicam	Meloxicam	40	suppressed
Morphine Sulfate	Morphine Sulfate	40	15
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	38	suppressed
Ibuprofen	Ibuprofen	37	suppressed
Lamotrigine	Lamotrigine	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	16
Xtampza Er	Oxycodone Myristate	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Buspirone Hcl	Buspirone Hcl	33	14
Levetiracetam	Levetiracetam	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Prednisone	Prednisone	31	15
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Spironolactone	Spironolactone	29	13
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Carisoprodol	Carisoprodol	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Risperidone	Risperidone	26	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	25	12
Propranolol Hcl	Propranolol Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Finasteride	Finasteride	24	suppressed
Methenamine Hippurate	Methenamine Hippurate	24	suppressed
Lacosamide	Lacosamide	23	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Phenobarbital	Phenobarbital	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Ozempic	Semaglutide	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Atenolol	Atenolol	17	suppressed
Lactulose	Lactulose	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Nystatin	Nystatin	16	suppressed
Rivastigmine	Rivastigmine	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Atrovent Hfa	Ipratropium Bromide	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Digoxin	Digoxin	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Movantik	Naloxegol Oxalate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Belsomra	Suvorexant	12	suppressed
Clonidine	Clonidine	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Invega Sustenna	Paliperidone Palmitate	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Armodafinil	Armodafinil	11	suppressed
Carvedilol	Carvedilol	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Glipizide	Glipizide	11	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error